Thermo Introduces New LIMS Datasheet For the Drug Discovery and Development Industry

Thermo Electron Corporation (NYSE: TMO) has produced a new datasheet to provide an overview of the capabilities of its purpose-built Watson™ Laboratory Information Management System (LIMS).

Thermo’s Watson is a highly specialized protocol-driven LIMS, specifically designed to support drug metabolism and pharmacokinetic (DMPK) studies in drug discovery and development.

The new datasheet is entitled “Watson LIMS – The acknowledged standard in LIMS for bioanalytical laboratories” and is aimed at scientists in biotechnology and pharmaceutical companies and Contract Research Organizations (CROs). As well as providing an overview of the data processing capabilities of Thermo’s Watson LIMS, the new datasheet discusses the challenges facing pharmaceutical companies and CROs to decrease costs while optimizing efficiency. As a commercial-off-the-shelf solution, Watson reduces risk and total cost of ownership compared to generic LIMS, which require customization to meet the specific needs of bioanalytical laboratories.

The datasheet describes benefits that have made Watson the leading LIMS deployed in bioanalytical laboratories. Watson LIMS requires minimal configuration, thereby resulting in fast implementation, validation, upgrades and immediate efficiency gains. It is equipped with key functionality specific to the DMPK laboratory, including flexible protocol-based study design, assay/method standardization and management, integrated sample management and a configurable re-assay decision tree.

To obtain a free-of-charge copy of the new datasheet, simply download it in pdf format from: www.thermo.com/com/cda/product/detail/1,,10120349,00.html